Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI

Authors

Farah Deba, University of Texas at Tyler
Kemburli Munoz, Texas A&M HSC
Eloisa Peredia, University of Texas at Tyler
Gustav Akk, Washington University School of Medicine in St. Louis
Ayman K Hamouda, University of Texas at Tyler

Journal

Journal of Biological Chemistry

Publication Date

1-1-2022

Volume

298

Issue

1

First Page

101455

Document Type

Open Access Publication

DOI

10.1016/j.jbc.2021.101455

Rights and Permissions

Deba F, Munoz K, Peredia E, Akk G, Hamouda AK. Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI. J Biol Chem. 2022 Jan;298(1):101455. doi: 10.1016/j.jbc.2021.101455. This research was originally published in Journal of Biological Chemistry. Deba F, Munoz K, Peredia E, Akk G, Hamouda AK. Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI. Journal of Biological Chemistry. 2022; 298(1):101455. © the American Society for Biochemistry and Molecular Biology. © 2021 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Deba, Farah; Munoz, Kemburli; Peredia, Eloisa; Akk, Gustav; and Hamouda, Ayman K, "Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI." Journal of Biological Chemistry. 298, 1. 101455 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11211